Insiders Bearish on These Healthcare Stocks in December

The DJIA remains above 12,250 and the S&P 500 Index trades above 1,260 today. Insiders were bearish on these stocks in the Healthcare sector for the week ending December 16th, 2011.

Ronda E Stryker who is Director at Stryker Corp. (NYSE:SYK), sold 9,000 shares on Dec 09 at $47.77 per share for a total value of $429,968. The shares recently traded at $45.78, down $2.07, or 4.33% since the insider sale. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Get the most recent company news and stock data here >>

Robert H Kluge who is Corp VP; Pres. X-Ray Products at Varian Medical Systems Inc. (NYSE:VAR), sold 15,483 shares on Dec 13 at $65.00 per share for a total value of $1,006,395. The shares recently traded at $63.20, down $0.82, or 1.28% since the insider sale. About the company: Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The Company also supplies products that include x-ray tubes, linear accelerators, digital image detectors, image processing software and image detection products. Get the most recent company news and stock data here >>

Anthony Welters who is EVP, UnitedHealth Group at Unitedhealth Group, Inc. (NYSE:UNH), sold 18,254 shares on Dec 14 at $48.16 per share for a total value of $879,136. The shares recently traded at $48.97, up $1.21, or 2.53% since the insider sale. About the company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers. Get the most recent company news and stock data here >>

Perier I Francis Jr who is EVP Finance & Admin. & CFO at Forest Laboratories Inc. (NYSE:FRX), sold 10,000 shares on Dec 14 at $28.55 per share for a total value of $285,510. The shares recently traded at $28.78, up $0.23, or 0.81% since the insider sale. About the company: Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest’s products are marketed in the United States and eastern Europe. Get the most recent company news and stock data here >>

Elisha W Finney who is SVP, Finance and CFO at Varian Medical Systems Inc. (NYSE:VAR), sold 4,000 shares on Dec 14 at $63.38 per share for a total value of $253,526. The shares recently traded at $63.20, up $0.11, or 0.17% since the insider sale. About the company: Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The Company also supplies products that include x-ray tubes, linear accelerators, digital image detectors, image processing software and image detection products. Get the most recent company news and stock data here >>

Richard T Burke who is Director at Unitedhealth Group, Inc. (NYSE:UNH), sold 10,000 shares on Dec 16 at $49.10 per share for a total value of $491,011. The shares recently traded at $48.97, down $0.03, or 0.06% since the insider sale. About the company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers. Get the most recent company news and stock data here >>

Gary M Cohen who is Executive Vice President at Becton, Dickinson and Company (NYSE:BDX), sold 4,500 shares on Dec 15 at $71.49 per share for a total value of $321,705. The shares recently traded at $70.66, down $0.49, or 0.69% since the insider sale. About the company: Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company’s products are used by health care professionals, medical research institutions, and the general public. Becton’s products are marketed worldwide. Get the most recent company news and stock data here >>

James T Crines who is EVP, Finance and CFO at Zimmer Holdings, Inc. (NYSE:ZMH), sold 15,504 shares on Dec 15 at $48.16 per share for a total value of $746,715. The shares recently traded at $47.70, down $0.04, or 0.08% since the insider sale. About the company: Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Zimmer markets its products in the United States and other countries around the world. Get the most recent company news and stock data here >>

Jerome Lynch who is SVP-Sales at Forest Laboratories Inc. (NYSE:FRX), sold 14,000 shares on Dec 15 at $28.80 per share for a total value of $403,200. The shares recently traded at $28.78, down $0.05, or 0.17% since the insider sale. About the company: Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest’s products are marketed in the United States and eastern Europe. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from publicly available SEC filings. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>